BACKGROUND Mazabraud’s syndrome(MS)is a rare and slowly progressive benign disease characterized by the concurrent presence of fibrous dysplasia of bone and intramuscular myxoma,and is thought to be associated with m...BACKGROUND Mazabraud’s syndrome(MS)is a rare and slowly progressive benign disease characterized by the concurrent presence of fibrous dysplasia of bone and intramuscular myxoma,and is thought to be associated with mutations of the GNAS gene.To date,only about 100 cases of MS have been reported in the literature,but its standard treatment strategy remains unclear.CASE SUMMARY We report two cases of MS in young women who underwent different treatments based on their symptoms and disease manifestations.The first patient,aged 37,received internal fixation and intravenous bisphosphonate for a pathological fracture of the right femoral neck,excision of a right vastus medialis myxoma was subsequently performed for pain control,and asymptomatic psoas myxomas were monitored without surgery.Genetic testing confirmed a GNAS gene mutation in this patient.The second patient,aged 24,underwent right vastus intermedius muscle myxoma resection,and conservative treatment for fibrous dysplasia of the ilium.These patients were followed-up for 17 months and 3 years,respectively,and are now in a stable condition.CONCLUSION Various treatments have been selected for MS patients who suffer different symptoms.The main treatment for myxomas is surgical resection,while fibrous dysplasia is selectively treated if the patient experiences pathological fracture or severe pain.However,given the documented instances of malignant transformation of fibrous dysplasia in individuals with MS,close follow-up is necessary.展开更多
AIM： To assess the efficacy of premedicaton with pronase or N-acetylcysteine （NAC） at 20 min before upper gastrointestinal （UGI） endoscopy and to determine whether pronase or NAC pretreatment influences the relia...AIM： To assess the efficacy of premedicaton with pronase or N-acetylcysteine （NAC） at 20 min before upper gastrointestinal （UGI） endoscopy and to determine whether pronase or NAC pretreatment influences the reliability of the rapid urease test. METHODS： A total of 146 patients were prospectively and randomly assigned into the study groups according to different premedications before endoscopy. One endoscopist assessed mucosal visibility （MV） with scores ranged from 1 to 4 at four sites in the stomach. The sum of the MV scores from these four locations was defined as the total mucosal visibility （TMV） score. Identification of Hpylori was performed using CLO test, histology, and serology. RESULTS： The Group with pronase premedication had a significantly lower TMV score than did the groups with gascon and gascon water （P 〈 0.001 and P 〈 0.01, respectively）. The group with NAC had a significantly lower TMV score than the group with gascon （P 〈 0.01） and a trend of a lower MV score than the group with gascon water （P = 0.06）. The THV score did not significantly differ between the group with pronase and the group with NAC （P = 0.39 and P = 0.14, respectively）. The sensitivity and specifidty of the CLO test were 92.5% and 93.9%, respectively, in groups premedicated with pronase and NAC together.CONCLUSION： Premedication with pronase or NAC at 20 min before UGI endoscopy improves the mucosal visibility of the stomach. Neither pronase nor NAC produces any obvious interference with the CLO test for the identification of H pylori infection.展开更多
Numerous non-cyanide leaching lixiviants have been developed,among which thiosulfate is considered the most promising alternative to cyanide due to its non-toxicity,low price,high leaching rate and excellent character...Numerous non-cyanide leaching lixiviants have been developed,among which thiosulfate is considered the most promising alternative to cyanide due to its non-toxicity,low price,high leaching rate and excellent characteristics in dealing with carbonaceous and copper-bearing gold ores.The traditional copper−ammonia−thiosulfate system has been studied extensively.However,with many years of process development,there are still some problems and challenges with this gold leaching system.A series of studies using nickel-,cobalt-and ferric-based catalyst to substitute copper have been conducted with the purpose of reducing the consumption of thiosulfate.A variety of non-ammonia thiosulfate leaching systems including oxygen−thiosulfate,copper−thiosulfate,copper−EDA−thiosulfate,ferric−EDTA−thiosulfate,and ferric−oxalate−thiosulfate leaching systems have been also developed to eliminate the potential side-effect of ammonia.In this review,the basic theory and process development of some main gold leaching systems based on thiosulfate solutions were systematically summarized to illustrate the research status on thiosulfate leaching process.The potential effects of various additives such as organic ligands containing amino,carboxyl or hydroxy functional groups on gold thiosulfate leaching were described in detail.The potential opportunity and challenge for promoting the industrial development of thiosulfate-based gold leaching systems were also discussed.展开更多
基金Supported by National Natural Science Foundation of China,No.81702662.
文摘BACKGROUND Mazabraud’s syndrome(MS)is a rare and slowly progressive benign disease characterized by the concurrent presence of fibrous dysplasia of bone and intramuscular myxoma,and is thought to be associated with mutations of the GNAS gene.To date,only about 100 cases of MS have been reported in the literature,but its standard treatment strategy remains unclear.CASE SUMMARY We report two cases of MS in young women who underwent different treatments based on their symptoms and disease manifestations.The first patient,aged 37,received internal fixation and intravenous bisphosphonate for a pathological fracture of the right femoral neck,excision of a right vastus medialis myxoma was subsequently performed for pain control,and asymptomatic psoas myxomas were monitored without surgery.Genetic testing confirmed a GNAS gene mutation in this patient.The second patient,aged 24,underwent right vastus intermedius muscle myxoma resection,and conservative treatment for fibrous dysplasia of the ilium.These patients were followed-up for 17 months and 3 years,respectively,and are now in a stable condition.CONCLUSION Various treatments have been selected for MS patients who suffer different symptoms.The main treatment for myxomas is surgical resection,while fibrous dysplasia is selectively treated if the patient experiences pathological fracture or severe pain.However,given the documented instances of malignant transformation of fibrous dysplasia in individuals with MS,close follow-up is necessary.
基金supported by the National Natural Science Foundation of China(No.52174271)Fundamental Research Funds for Central Universities of China(No.N182502044)。
基金Supported by a grant of TMU93-AE1-B-0793 MSH-TMU-09 of Taipei Medical University
文摘AIM： To assess the efficacy of premedicaton with pronase or N-acetylcysteine （NAC） at 20 min before upper gastrointestinal （UGI） endoscopy and to determine whether pronase or NAC pretreatment influences the reliability of the rapid urease test. METHODS： A total of 146 patients were prospectively and randomly assigned into the study groups according to different premedications before endoscopy. One endoscopist assessed mucosal visibility （MV） with scores ranged from 1 to 4 at four sites in the stomach. The sum of the MV scores from these four locations was defined as the total mucosal visibility （TMV） score. Identification of Hpylori was performed using CLO test, histology, and serology. RESULTS： The Group with pronase premedication had a significantly lower TMV score than did the groups with gascon and gascon water （P 〈 0.001 and P 〈 0.01, respectively）. The group with NAC had a significantly lower TMV score than the group with gascon （P 〈 0.01） and a trend of a lower MV score than the group with gascon water （P = 0.06）. The THV score did not significantly differ between the group with pronase and the group with NAC （P = 0.39 and P = 0.14, respectively）. The sensitivity and specifidty of the CLO test were 92.5% and 93.9%, respectively, in groups premedicated with pronase and NAC together.CONCLUSION： Premedication with pronase or NAC at 20 min before UGI endoscopy improves the mucosal visibility of the stomach. Neither pronase nor NAC produces any obvious interference with the CLO test for the identification of H pylori infection.
基金financial supports from the Fundamental Research Funds for Central Universities of China (No. N182502044)。
文摘Numerous non-cyanide leaching lixiviants have been developed,among which thiosulfate is considered the most promising alternative to cyanide due to its non-toxicity,low price,high leaching rate and excellent characteristics in dealing with carbonaceous and copper-bearing gold ores.The traditional copper−ammonia−thiosulfate system has been studied extensively.However,with many years of process development,there are still some problems and challenges with this gold leaching system.A series of studies using nickel-,cobalt-and ferric-based catalyst to substitute copper have been conducted with the purpose of reducing the consumption of thiosulfate.A variety of non-ammonia thiosulfate leaching systems including oxygen−thiosulfate,copper−thiosulfate,copper−EDA−thiosulfate,ferric−EDTA−thiosulfate,and ferric−oxalate−thiosulfate leaching systems have been also developed to eliminate the potential side-effect of ammonia.In this review,the basic theory and process development of some main gold leaching systems based on thiosulfate solutions were systematically summarized to illustrate the research status on thiosulfate leaching process.The potential effects of various additives such as organic ligands containing amino,carboxyl or hydroxy functional groups on gold thiosulfate leaching were described in detail.The potential opportunity and challenge for promoting the industrial development of thiosulfate-based gold leaching systems were also discussed.
